| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $490.6 | $91.6 | $140 | |
| Short term investments | ||||
| Net receivables | $1976.8 | $1817.8 | $1763 | $1768.4 |
| Inventory | $97.7 | $99.9 | $101.4 | $97.3 |
| Total current assets | $2348.4 | $2659.7 | $2273.6 | $2381 |
| Long term investments | $178 | $143.3 | $163.6 | |
| Property, plant & equipment | $11756.2 | $11446.5 | $11310.5 | $11350.9 |
| Goodwill & intangible assets | $16328.3 | $16334.9 | $16330.7 | |
| Total noncurrent assets | $29274.4 | $29108.1 | $29029.1 | |
| Total investments | $178 | $143.3 | $163.6 | |
| Total assets | $31814.2 | $31934.1 | $31381.7 | $31410.1 |
| Current liabilities | ||||
| Accounts payable | $1225.4 | $1285.5 | $1179.2 | $1411.5 |
| Deferred revenue | $472.5 | $472.2 | $467.3 | |
| Short long term debt | $1432.9 | $1431.9 | $932.3 | |
| Total current liabilities | $3641.5 | $4533.6 | $4325.9 | $4228.3 |
| Long term debt | $12047.4 | $11526.8 | $11400.1 | $11887.1 |
| Total noncurrent liabilities | $16394.2 | $16235.2 | $16638.3 | |
| Total debt | $12959.7 | $12832 | $12819.4 | |
| Total liabilities | $20585.4 | $20927.8 | $20561.1 | $20866.6 |
| Shareholders' equity | ||||
| Retained earnings | $9443.9 | $9060.7 | $8717.9 | $8433.9 |
| Other shareholder equity | -$18.6 | -$9.1 | -$5.3 | -$12.1 |
| Total shareholder equity | $11005.1 | $10819.8 | $10542.3 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $140 | $143.4 | $29 | $38.2 |
| Short term investments | ||||
| Net receivables | $1768.4 | $1677.2 | $1271.4 | $1091.3 |
| Inventory | $97.3 | $96.6 | $72.2 | $59.1 |
| Total current assets | $2381 | $2357.1 | $1710.8 | $1521.8 |
| Long term investments | $163.6 | $127.6 | $139 | $149.1 |
| Property, plant & equipment | $11350.9 | $10743.2 | $9232.1 | $8726.2 |
| Goodwill & intangible assets | $16330.7 | $14798.7 | $13085.5 | $12219.5 |
| Total noncurrent assets | $29029.1 | $26695.8 | $23244.2 | $21912.2 |
| Total investments | $163.6 | $127.6 | $139 | $149.1 |
| Total assets | $31410.1 | $29050.9 | $24955 | $23434 |
| Current liabilities | ||||
| Accounts payable | $1411.5 | $1221.8 | $910 | $779 |
| Deferred revenue | $467.3 | $443 | $381.3 | $345.6 |
| Short long term debt | $932.3 | $456 | $8.2 | $168.1 |
| Total current liabilities | $4228.3 | $3388.3 | $2415.6 | $2282 |
| Long term debt | $11887.1 | $11328.8 | $9546.2 | $8766.1 |
| Total noncurrent liabilities | $16638.3 | $15975.4 | $13559.7 | $12663.2 |
| Total debt | $12819.4 | $11785.5 | $9554.4 | $8934.2 |
| Total liabilities | $20866.6 | $19364.9 | $15975.3 | $14945.2 |
| Shareholders' equity | ||||
| Retained earnings | $8433.9 | $7356.3 | $6475.6 | $5751.8 |
| Other shareholder equity | -$12.1 | -$12.1 | -$14.6 | -$12.4 |
| Total shareholder equity | $10542.3 | $9686 | $8978.9 | $8483.9 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4076.2 | $4048 | $3861.7 | $3831.6 |
| Cost of revenue | $2382.6 | $2283.2 | $2264.2 | |
| Gross Profit | $1709.3 | $1665.4 | $1578.5 | $1567.4 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $407.6 | $414 | $431.4 | |
| Total operating expenses | $854.7 | $851.6 | $833.1 | $862.1 |
| Operating income | $813.8 | $745.4 | $705.3 | |
| Income from continuing operations | ||||
| EBIT | $781.9 | $738.3 | $612.2 | |
| Income tax expense | $80.6 | $142.1 | $145.2 | $43.2 |
| Interest expense | -$207.3 | $128.3 | $139.3 | $129.4 |
| Net income | ||||
| Net income | $565.7 | $511.5 | $453.8 | $439.6 |
| Income (for common shares) | $511.5 | $453.8 | $439.6 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14964.5 | $13511.3 | $11295 | $10153.6 |
| Cost of revenue | $8942.2 | $8205 | $6737.7 | $6100.5 |
| Gross Profit | $6022.3 | $5306.3 | $4557.3 | $4053.1 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1608.7 | $1454.3 | $1195.8 | $1053 |
| Total operating expenses | $3234.6 | $2916.9 | $2481.6 | $2339.9 |
| Operating income | $2787.7 | $2389.4 | $2075.7 | $1713.2 |
| Income from continuing operations | ||||
| EBIT | $2699.3 | $2227.1 | $1887.8 | $1495.9 |
| Income tax expense | $460.1 | $343.9 | $282.8 | $173.1 |
| Interest expense | $508.2 | $395.6 | $314.6 | $355.6 |
| Net income | ||||
| Net income | $1731 | $1487.6 | $1290.4 | $967.2 |
| Income (for common shares) | $1731 | $1487.6 | $1290.4 | $967.2 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $511.5 | $453.8 | $439.6 | |
| Operating activities | ||||
| Depreciation | $439.8 | $425.8 | $426.7 | |
| Business acquisitions & disposals | -$33 | -$166.3 | -$1009.5 | |
| Stock-based compensation | $10.6 | $11.2 | $9.2 | |
| Total cash flows from operations | $1099.4 | $811.5 | $898.5 | |
| Investing activities | ||||
| Capital expenditures | -$400.5 | -$512.1 | -$543.7 | |
| Investments | -$0.1 | -$0.5 | -$15.1 | |
| Total cash flows from investing | -$1748.5 | -$433.8 | -$678.9 | -$1566 |
| Financing activities | ||||
| Dividends paid | -$504.8 | -$168.5 | -$168.3 | -$168.6 |
| Sale and purchase of stock | -$163.3 | -$25.3 | -$68.3 | |
| Net borrowings | $103.1 | -$4 | $883.5 | |
| Total cash flows from financing | -$1188.1 | -$233.4 | -$201.2 | $641.1 |
| Effect of exchange rate | $1.1 | $1.2 | -$0.5 | $0.1 |
| Change in cash and equivalents | -$21.5 | $433.4 | -$69.1 | -$26.3 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1731 | $1487.6 | $1290.4 | $967.2 |
| Operating activities | ||||
| Depreciation | $1599.3 | $1441.2 | $1268.2 | $1158.8 |
| Business acquisitions & disposals | -$2058.9 | -$2987.9 | -$1175.4 | -$736.6 |
| Stock-based compensation | $40.9 | $38.8 | $57 | $37.3 |
| Total cash flows from operations | $3617.8 | $3190 | $2786.7 | $2471.6 |
| Investing activities | ||||
| Capital expenditures | -$1601.9 | -$1421.2 | -$1296.8 | -$1164.5 |
| Investments | -$15.8 | $0.1 | $7.1 | -$21.7 |
| Total cash flows from investing | -$3666.8 | -$4423 | -$2466.1 | -$1922.8 |
| Financing activities | ||||
| Dividends paid | -$638.1 | -$592.9 | -$552.6 | -$522.5 |
| Sale and purchase of stock | -$263 | -$217.1 | -$264.2 | -$94.9 |
| Net borrowings | $982.6 | $2164.6 | $542.1 | $21.1 |
| Total cash flows from financing | $61.9 | $1344.2 | -$329.2 | -$612 |
| Effect of exchange rate | $0.3 | -$2.5 | ||
| Change in cash and equivalents | $13.2 | $108.7 | -$8.6 | -$63.2 |
| Market cap | $69.90B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 313.30M |
| Revenue | $15.82B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $1.97B |
| Revenue Q/Q | 6.54% |
| Revenue Y/Y | 7.88% |
| P/E ratio | 35.47 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 4.42 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $6.29 |
|---|---|
| ROA | 6.23% |
| ROE | N/A |
| Debt/Equity | 1.98 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.64 |
| Quick ratio | 0.62 |